Similar articles

• Physiologic basis for the therapeutic use of catecholamines.

  Rosenblum R. Rosenblum R. Am Heart J. 1974 Apr;87(4):527-30. doi: 10.1016/0002-8703(74)90180-x. Am Heart J. 1974. PMID: 4817111 No abstract available.
• Cardiovascular effects of various agents on cardiogenic shock.

  Fukushima K. Fukushima K. Jpn Circ J. 1974 Jun;38(6):509-13. doi: 10.1253/jcj.38.509. Jpn Circ J. 1974. PMID: 4279996 No abstract available.
• Shock in myocardial infarction--medical treatment.

  Kuhn LA. Kuhn LA. Am J Cardiol. 1970 Dec;26(6):578-87. doi: 10.1016/0002-9149(70)90410-8. Am J Cardiol. 1970. PMID: 4938984 Review. No abstract available.
• [Comparison between the peripheral vascular action of dopamine, norepinephrine, and isopropylnoradrenaline. Experimental study].

  Marchetti GV, Merlot L, Noseda V. Marchetti GV, et al. Arch Mal Coeur Vaiss. 1973 Apr;66(4):481-5. Arch Mal Coeur Vaiss. 1973. PMID: 4200210 French. No abstract available.
• Use of catecholamines in acute myocardial infarction.

  Dixon DW, Loeb HS, Gunnar RM. Dixon DW, et al. Herz. 1979 Oct;4(5):385-96. Herz. 1979. PMID: 391685 Review.